Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
37.15
+0.82 (2.26%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Phibro Animal Health Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 54.93 | 68.04 | 70.61 | 41.28 | 74.25 | 50.21 |
Short-Term Investments | 22.52 | 9 | 44 | 40 | 17 | 43 |
Cash & Short-Term Investments | 77.45 | 77.04 | 114.61 | 81.28 | 91.25 | 93.21 |
Cash Growth | 10.09% | -32.78% | 41.01% | -10.92% | -2.11% | 2.05% |
Accounts Receivable | 221.55 | 227.98 | 169.45 | 163.48 | 166.54 | 146.85 |
Inventory | 539.7 | 444.43 | 265.91 | 277.57 | 259.16 | 216.31 |
Other Current Assets | 55.37 | 61.16 | 51.02 | 63.39 | 49.29 | 42.53 |
Total Current Assets | 894.07 | 810.61 | 601 | 585.72 | 566.23 | 498.91 |
Net Property, Plant & Equipment | 359.27 | 354.69 | 203.3 | 195.57 | 165.49 | 154.71 |
Other Intangible Assets | 31.69 | 36.47 | 45.03 | 54.99 | 63.86 | 62.28 |
Goodwill | 59.89 | 59.65 | 54.56 | 53.27 | 53.23 | 52.68 |
Other Long-Term Assets | 100.21 | 99.49 | 78.3 | 81.85 | 82.89 | 72.75 |
Total Assets | 1,445 | 1,361 | 982.18 | 971.4 | 931.7 | 841.33 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 129.64 | 138.2 | 85.57 | 73.85 | 95.6 | 68.36 |
Accrued Expenses | 129.4 | 139.02 | 88.79 | 79.85 | 80.24 | 86.38 |
Current Portion of Long-Term Debt | 22.83 | 16.25 | 29.8 | 22.3 | 15 | 9.38 |
Total Current Liabilities | 281.87 | 293.47 | 204.15 | 176 | 190.83 | 164.12 |
Long-Term Debt | 712.69 | 702.44 | 458.29 | 452.54 | 417.93 | 382.71 |
Other Long-Term Liabilities | 88.74 | 79.31 | 63.11 | 60.35 | 60.5 | 55.97 |
Total Long-Term Liabilities | 801.42 | 781.75 | 521.4 | 512.89 | 478.43 | 438.68 |
Total Liabilities | 1,083 | 1,075 | 725.54 | 688.89 | 669.26 | 602.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 138.18 | 137 | 136.28 | 135.8 | 135.8 | 135.8 |
Accumulated Other Comprehensive Income | -112.47 | -124.02 | -123.53 | -114.21 | -121.11 | -115.29 |
Retained Earnings | 336.12 | 272.7 | 243.89 | 260.91 | 247.75 | 218.02 |
Shareholders' Equity | 361.83 | 285.68 | 256.64 | 282.51 | 262.44 | 238.53 |
Total Liabilities & Equity | 1,445 | 1,361 | 982.18 | 971.4 | 931.7 | 841.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 735.52 | 718.69 | 488.08 | 474.84 | 432.93 | 392.09 |
Net Cash (Debt) | -658.07 | -641.65 | -373.47 | -393.56 | -341.68 | -298.87 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -16.09 | -15.77 | -9.22 | -9.72 | -8.44 | -7.38 |
Book Value | 361.83 | 285.68 | 256.64 | 282.51 | 262.44 | 238.53 |
Book Value Per Share | 8.84 | 7.02 | 6.34 | 6.97 | 6.48 | 5.89 |
Tangible Book Value | 270.25 | 189.57 | 157.05 | 174.25 | 145.36 | 123.57 |
Tangible Book Value Per Share | 6.61 | 4.66 | 3.88 | 4.30 | 3.59 | 3.05 |